# Development of monoclonal antibody-mediated interventions to combat malaria

> **NIH NIH N43** · SANARIA, INC. · 2022 · $298,596

## Abstract

This contract is to provide proof of concept studies for the development of a monoclonal antibody to combat P. falciparum malaria.

## Key facts

- **NIH application ID:** 10712195
- **Project number:** 75N93022C00022-0-9999-1
- **Recipient organization:** SANARIA, INC.
- **Principal Investigator:** SUSAN RUPPRECHT
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $298,596
- **Award type:** —
- **Project period:** 2022-08-30 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10712195

## Citation

> US National Institutes of Health, RePORTER application 10712195, Development of monoclonal antibody-mediated interventions to combat malaria (75N93022C00022-0-9999-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10712195. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*